Improved preparation of amyloid-β peptides using DBU as Nα-Fmoc deprotection reagent

Journal of Peptide Science

Volumn 7, Issue 9, 2001, Pages 488-494

  Tickler, Anna K ^a   Barrow, Colin J ^a,b   Wade, John D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Ocean Nutrition Canada Ltd   (Canada)

Author keywords

Alzheimer's disease; Amyloid peptides; Aspartimide; Continuous flow Fmoc solid phase peptide synthesis; DBU; Purification

Indexed keywords

9 FLUORENYLMETHYL CHLOROFORMATE; AMYLOID BETA PROTEIN; ASPARTIC ACID; N,N DIMETHYLFORMAMIDE; PEPTIDE; PIPERIDINE; REAGENT; SERINE;

ACYLATION; AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HYDROPHOBICITY; MASS SPECTROMETRY; MODEL; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

AMINO ACID SEQUENCE; AMINO ACIDS; AMYLOID BETA-PROTEIN; ASPARTIC ACID; BICYCLO COMPOUNDS, HETEROCYCLIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORENES; MOLECULAR SEQUENCE DATA; PEPTIDE BIOSYNTHESIS; PEPTIDES; PROTEIN BINDING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS;

EID: 0034802373     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.342     Document Type: Article

References (36)

1. Current concepts in the pathogenesis of Alzheimer's disease
2. The Aβ peptide and its role in Alzheimer's disease
3. Alzheimer's disease and oxidative stress: Implications of novel therapeutic approaches
4. Intracellular APP processing and Aβ production in Alzheimer's disease
5. Amidation of β-amyloid peptide strongly reduced the amyloidogenic activity without alteration of neurotoxicity
6. An atomic model for the pleated β-sheet structure of Aβ amyloid protofilaments
7. Temperature-dependent β-sheet formation in β-amyloid Aβ (1-40) peptide in water: Uncoupling β-structure folding from aggregation
8. Solution structures of β peptide and its constituent fragments: Relation to amyloid deposition
9. Immunisation with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
10. Aβ peptide immunisation reduces behavioural impairment and plaques in a model of Alzheimer's disease
11. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
12. Some 'difficult sequences' made easy
13. The synthesis of some peptides related to the amyloid β peptide 25-35: Use of N-(2-hydroxy-4-methoxybenzyl) protection
14. Preparation and purification of β-amyloid (1-43) via soluble, amide backbone protected intermediates
15. Improved preparation of β-amyloid (1-43): Structural insight leading to optimised positioning of N-(2-hydroxy-4-methoxybenzyl) (Hmb) backbone amide protection
16. Improved solid phase synthesis of amyloid proteins associated with neurodegenerative diseases
17. Coupling methods: Solid-phase formation of amide and ester bonds
18. Amino acid structure and 'difficult sequences' in solid phase peptide synthesis
19. Pseudo-prolines for accessing 'inaccessible' peptides
20. The synthesis of 'difficult' peptides using 2-hydroxy-4-methoxybenzyl or pseudoproline amino acid building blocks: A comparative study
21. Enhanced coupling efficiency in solid-phase peptide synthesis by microwave irradiation
22. Solid-phase peptide synthesis at elevated temperatures: A search for an optimised synthesis of unsulfated cholecystokinin-12
23. Incomplete Fmoc deprotection in solid-phase synthesis of peptides
24. A survey of potential problems and quality control in peptide synthesis by fluorenylmethoxycarbonyl procedure
25. α-deprotecting reagent for the fluorenylmethoxycarbonyl group in continuous flow solid phase peptide synthesis
26. SPPS of difficult sequences. A comparison of chemical conditions, synthetic strategies and on-line monitoring
27. Oligomerization and toxicity of β-amyloid-42 implicated in Alzheimer's disease
28. Chemical synthesis of peptides and proteins
29. Sequence dependence of aspartimide formation during 9-fluorenylmethyoxycarbonyl solid-phase peptide synthesis
30. α-deprotection reagent
31. A new protecting group for aspartic acid that minimises piperidine-catalysed aspartimide formation in Fmoc solid-phase peptide synthesis
32. Design of protecting groups for the [beta]-carboxylic group of aspartic acid that minimize base-catalysed aspartimide formation
33. t)-containing peptides by the use of N-(2-hydroxy-4-methoxybenzyl) (Hmb) backbone amide protection
34. t)-containing peptides
35. Conformations of β-amyloid in solution (Reply)